Case | HBS Case Collection | March 1997

BioTransplant, Inc.: Initial Public Offering, January 1996

by Paul A. Gompers and Alexander Tsai

Abstract

Examines the decision to go public. BioTransplant is an early stage biotechnology company that must decide how to finance its research and development. The pros and cons of public offerings are analyzed versus alternative financing sources.

Keywords: Initial Public Offering; Financing and Loans; Research and Development; Going Public;

Citation:

Gompers, Paul A., and Alexander Tsai. "BioTransplant, Inc.: Initial Public Offering, January 1996." Harvard Business School Case 297-095, March 1997.